MedTrace Logo

PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma

NCT06322927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2026-05-08

No results posted yet for this study

Summary

This is a qualitative (interview) study to explore the experiences of people receiving treatment for MM and to understand what matters most to participants when making treatment decisions.

Conditions

Interventions

OTHER

Patient Interview

Participants will be asked to take part in a 30-60 minute interview to understand their treatment experiences and preferences.

Sponsors & Collaborators

  • CellCentric Ltd.

    collaborator INDUSTRY

  • The Christie NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Sally Taylor, PhD · The Christie NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-05
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06322927 on ClinicalTrials.gov